Objective. To describe the diagnosis and management of renal disease in three paediatric cases of hypocomplementaemic urticarial vasculitis syndrome (HUVS).
Introduction
Urticarial vasculitis (UV) is characterized by persistent urticarial lesions with histological evidence of leucocytoclastic vasculitis [1] . Hypocomplementaemic UV syndrome (HUVS) [2] is a rare disease, comprising 18% of patients with UV [3] , characterized by complement activation with a marked decrease in circulating C1q. HUVS can have systemic features involving the musculoskeletal, pulmonary, renal and gastrointestinal systems; peak incidence is in the fifth decade of life. The exact prevalence of HUVS in children is unknown [49] . HUVS is diagnosed [1, 7] in the presence of both chronic urticarial skin lesions and hypocomplementaemia (major criteria), plus at least two of the following minor criteria: leucocytoclastic vasculitis, arthralgia or arthritis, uveitis or episcleritis, glomerulonephritis, recurrent abdominal pain and plasmatic C1q precipitin. Some authors have emphasized the overlapping features of HUVS and SLE and consider them to be part of the same disease spectrum [10] . We describe three paediatric cases of HUVS with renal involvement. oedema and arthralgia. Blood pressure was normal. Over the following months she also developed abdominal symptoms (cramps, nausea and diarrhoea) and conjunctivitis. Symptomatic therapy with antihistamines and NSAIDs was ineffective. Skin biopsy revealed leucocytoclastic vasculitis. RF, ANA, anti-dsDNA, anti-ENA, aCLs, cANCA and pANCA were repeatedly negative; serum C3 and C4 were normal. Forty months after urticaria onset, isolated microhaematuria appeared, associated with low C3 and C4 levels. Renal ultrasonography and pulmonary function tests were normal.
Due to persistent microhaematuria, renal biopsy was performed, revealing mesangial glomerulonephritis with membranous features. Arterioles showed diffuse and moderate intimal hyalinosis. IF revealed positivity for IgG (3+), IgM (1+), IgA (1+), C3 (2+), C1q (1+), kappa (3+) and lambda (2+) light chains in the glomerular basement membrane and mesangium.
In the absence of proteinuria, the patient started oral glucocorticoid therapy (prednisone 1 mg/kg/day for 1 month, progressively tapered to 0.5 mg/kg/48 h). During follow-up, the frequency and extension of urticarial flares gradually increased; microhaematuria persisted, without proteinuria. Microcytic anaemia was detected and the patient started iron therapy; C3 and C4 levels remained low. A second kidney biopsy performed 18 months later showed a slight increase in immune deposits despite treatment (IgA 3+, IgG 3+, IgM 3+, C3 2+, C1q 3+ and kappa and lambda light chains 3+) and the appearance of mild intimal fibrosis of medium-size arterioles. For this reason, MMF (1200 mg/m 2 /day) and dapsone (1.5 mg/kg/day) were added, with progressive resolution of skin lesions but persistence of low C3 and C4 levels and microhaematuria.
Patient 2
A Caucasian female developed recurrent urticarial lesions at 4 years of age that were treated with oral betametasone and antihistamines with partial remission. Intermittent arthralgia appeared, followed, after 8 months, by an acute febrile illness with bilateral coxalgia, urticarial lesions, especially on the lower limbs, and a 2/6 systolic murmur (mild mitralic insufficiency). Laboratory evaluation showed severe anaemia (haemoglobin 5.5 g/dl). RF, ANA, anti-dsDNA, ENA, aCL, cANCA and pANCA were repeatedly negative and serum C3 and C4 were normal; skin biopsy showed leucocytoclastic vasculitis. She was treated with antibiotics, NSAIDs and antihistamines. Subsequent urinalyses showed persistent microhaematuria and intermittent mild proteinuria (0.20.35 g/day). At 9 years of age, arthralgia and urticarial lesions became more frequent and severe. Blood pressure was at the upper limit of normal. C3 and C4 were low. Pulmonary function tests demonstrated mild respiratory insufficiency and pulmonary CT scan detected diffuse small nodules. Pulmonary biopsy revealed numerous hemosiderin-laden macrophages, alveolar septal thickening and lymphocytic vasculitis. Eye examination showed bilateral episcleritis. Abdominal ultrasonography revealed mild hepatomegaly and no renal abnormalities. In view of persistent microhaematuria and proteinuria, renal biopsy was performed, showing mesangial glomerulonephritis associated with focal necrotizing small-vessel vasculitis, focal tubular atrophy and focal interstitial fibrosis. IF was strongly positive (arteriolar IgA, IgG, IgM, C3, C1q and kappa and lambda light chains 3+; mesangial 2+). Treatment with prednisone (1 mg kg/day for 1 month, tapered to 0.5 mg/kg/48 h) and CYC (2 mg kg/day for 3 months) was started; AZA (1 mg/kg/day) was added, with partial control of the urticarial lesions. C3 and C4 normalized and proteinuria disappeared. However, upon prednisone tapering, C3 values decreased and proteinuria reappeared. Steroid and AZA dosages were therefore increased, with normalization of C3 and proteinuria.
Patient 3
A Caucasian boy developed urticaria with fever, abdominal pain, asthenia, lips and eyelids oedema and large joint arthritis at 9 years 5 months of age. Symptomatic therapy with NSAIDs and antihistamines was ineffective; oral glucocorticoid therapy produced an improvement in skin lesions. When steroids were withdrawn, the urticarial rash recurred and a skin biopsy was performed, revealing leucocytoclastic vasculitis responsive to renewed systemic glucocorticoid treatment. Ciclosporin, colchicine, anakinra and HCQ were used for brief periods with no clinical benefit.
At 11 years 10 months of age, anti-C1q antibodies were found to be markedly positive and a pulmonary function test revealed restrictive respiratory insufficiency with normal chest CT scan. Bronchoalveolar brush biopsy showed numerous hemosiderin-laden macrophages. Eye examination revealed bilateral conjunctivitis. Treatment with prednisone (2 mg/kg/day), AZA (1 mg/kg/day) and dapsone (1.5 mg/kg/day) was started. Urticarial rash, oedema and arthritis completely resolved. However, C3 and C4 serum concentrations remained markedly low and anti-C1q antibodies were persistently high. RF, ANA, anti-dsDNA, ENA, aCL, cANCA and pANCA were negative.
After 2 years of clinical remission, the patient voluntarily discontinued medication. After 3 months, markedly positive anti-dsDNA (1:5120) and significant proteinuria (2.5 g/ day) with microscopic haematuria appeared; renal function and blood pressure were normal. C3 and C4 were persistently reduced. Renal biopsy showed a glomerulonephritis with intense mesangial, endo-and extracapillary proliferation with initial tubular atrophy. IF revealed intense C1q (+++) and C3 (+++) positivity, with IgA +/À and negative IgG, IgM and fibrinogen. The patient received three i.v. methylprednisolone pulses (1 g each) and subsequently oral prednisone, i.v. CYC pulses (750 mg/m 2 ) every 3 weeks and dapsone. Proteinuria decreased to 1.4 g/day after the first month of therapy and anti-dsDNA decreased to 1:160, while C3 and C4 increased to 87 and 10 mg/dl, respectively. At the most recent follow-up, 4 months from starting CYC, proteinuria was absent. Clinical features and laboratory findings of the three patients at disease onset are reported in Table 1 . Fig. 1 shows renal biopsy findings in the three patients.
Discussion
HUVS is a rare immune complexmediated entity characterized by UV and persistent acquired hypocomplementaemia [1] with several systemic findings, affecting primarily female adults [7, 11] . The first paediatric patient with HUVS was described in 1985 [6]: recurrent urticaria and angio-oedema appeared at 2 years of age and severe hypocomplementaemic glomerulonephritis appeared at age 11 years, leading to end-stage renal disease 3 years later. To our knowledge, after this first report, seven other paediatric cases have been described [49] . In adults, renal involvement is present in $50% of subjects with HUVS. It is generally mild, often involves only proteinuria and microscopic haematuria and usually occurs within 4 years of onset of the cutaneous rash. Prognosis is generally good, with renal failure rarely developing [12, 13] . Conversely, renal involvement seems to be more severe in children and occurs earlier than in adults: rapidly progressive glomerulonephritis was described in four of eight reported paediatric patients, resulting in end-stage renal disease in three of them. Renal involvement may be absent at diagnosis, when cutaneous, joint and ocular manifestations are prevalent.
We report three paediatric patients with HUVS who developed renal involvement: all of them satisfied the two major diagnostic criteria for HUVS and at least two of the minor criteria (Table 1) . Renal involvement was absent at onset and urinary abnormalities appeared 9 months to 4 years later, similar to the four previously reported cases. In children with HUVS, renal involvement appears to be more severe and may occur much later during the disease course, suggesting that continuous monitoring of urinalysis is needed.
Urinary findings were heterogeneous: all of the patients developed persistent microhaematuria, which was isolated in patient 1, associated with mild proteinuria in patient 2 and associated with nephrotic syndrome in patient 3. Findings from their renal biopsies were also heterogeneous: patients 1 and 2, without increased levels of serum autoantibodies, shared a full-house IF (C3, C1q and Ig [14] . Two paediatric cases of HUVS associated with SLE have been reported [15, 16] . Other differential diagnoses have been reported (see supplementary Table S1 , available at Rheumatology Online). Finally, although dapsone is the recommended HUVS therapy [1, 11, 13] , its efficacy in renal involvement is unknown. It is interesting to note that in our series, patients 1 and 2 developed renal involvement before starting dapsone and patient 3 when he voluntarily stopped all treatments.
In conclusion, HUVS is rare in children and is usually followed by rheumatologists and dermatologists. Renal involvement is probably more common and severe than in adults and may appear later. Isolated microhaematuria can be the only sign of subclinical renal involvement: its role should not be underestimated and renal biopsy should be considered. Reports of rapid progression to end-stage renal disease suggest that prompt treatment is necessary.
Rheumatology key messages
. Renal involvement in paediatric hypocomplementaemic urticarial vasculitis syndrome (HUVS) is frequent. . Renal involvement in paediatric HUVS can lead to end-stage renal disease more often than in adults.
